39.53 USD
↘ 0.02 (0.05%)AT CLOSE (11:59 AM EDT)
Centessa Pharmaceuticals plc American Depositary Shares
CNTANASDAQ • USD
39.53
↘ 0.13 (0.33%)
POST MARKET (AS OF 05:49 PM EDT)
Post Market
AS OF 05:49 PM EDT
39.53
↘ 0.13 (0.33%)
Market: OPEN
Open?$39.65
High?$39.70
Low?$39.37
Prev. Close?$39.55
Volume?3.5M
Avg. Volume?3.4M
VWAP?$39.47
Rel. Volume?1.02x
Bid / Ask
Bid?$33.92 × 100
Ask?$45.60 × 100
Spread?$11.68
Midpoint?$39.76
Valuation & Ratios
Market Cap?6.1B
Shares Out?154.6M
P/E Ratio?N/A
P/B Ratio?11.61
EPS?-$1.28
Dividend?0.00%
Ex-Dividend?N/A
Technical Outlook
Loading...
Fundamental Outlook
Loading...
Short Interest
Loading...
Financial Health
Current Ratio?8.57Strong
Quick Ratio?8.57Strong
Cash Ratio?1.43Strong
Debt/Equity?0.21Low
ValuationRICHLY VALUED
Score50/100
P/E?N/A▾
P/B?11.61HIGH▾
P/S?407.79HIGH▾
P/FCF?N/A▾
EV/EBITDA?-29.8CHEAP▾
EV/Sales?411.05HIGH▾
Returns & Efficiency
ROE?-37.5%WEAK▾
ROA?-28.7%WEAK▾
Cash Flow & Enterprise
FCF?$-194188000
Enterprise Value?$6.2B
Related Companies
Loading...
News
Profile
Centessa Pharmaceuticals PLC is a clinical-stage biotechnology company pioneering a new class of therapeutics in orexin-based neuroscience. The group is developing a franchise of small molecule orexin receptor 2 (OX2R) agonists designed to address neuroscience diseases underpinned by dysregulation of wakefulness, attention, cognition, mood, and other symptoms, each grounded in the shared biology of the orexin pathway. The company's programs and Pipeline are the Orexin Receptor 2 Agonist Program and LockBody Technology Platform.
Employees
118
Market Cap
6.1B
Industry
PHARMACEUTICAL PREPARATIONS
Website
Listed
2021-05-28
Address
3RD FLOOR
ALTRINCHAM, CHESHIRE, X0 WA14 2DT
Phone: 44 7391 789784
ALTRINCHAM, CHESHIRE, X0 WA14 2DT
Phone: 44 7391 789784